A vital leap forward in cardiac testing

Speed meets accuracy where it matters most―the wait is over for hs-cTnI at the point of care.

When lives are at stake and every second is crucial, how can clinicians get the answers they need quickly? Every lost second in the emergency department has the potential to affect patient outcomes. The Atellica® VTLi Patient-side Immunoassay Analyzer provides the vital information clinicians need to aid in making decisions about patient disposition.

When ruling out a potential myocardial infarction (MI), every minute spent waiting on test results comes at a cost. Patients and their families are anxious, and clinicians and laboratory professionals are pressured to identify the problem quickly and accurately. Increased time to results adds congestion to an already busy emergency department. But what if ED staff had access to high-sensitivity troponin right at the point of care? Consider the value of adding a new tool at the clinician’s disposal that can provide high-sensitivity troponin I (hs-cTnI) results in just 8 minutes from a single fingerstick and patient interaction. The solution is intuitive, easily integrates into the existing workflow, and gives laboratory partners centralized control over decentralized testing, so ED throughput can be improved for efficiency and confidence. 

The Atellica® VTLi Patient-side Immunoassay Analyzer, powered by Magnotech® Technology, will transform your chest pain assessment process to benefit patients, clinicians, and your operational workflow. Because when it comes to assessing patients with symptoms of an MI in the ED, trust, time, and resources aren’t just valuable—they’re vital.